Temecula, CA, United States of America

Ronald Farnbach

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Cardiovascular Systems, Inc.. Active years: 2014.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald Farnbach

Introduction

Ronald Farnbach is a notable inventor based in Temecula, California. He has made significant contributions to the field of engineering, particularly in the medical device industry. His work focuses on mechanisms that enhance the functionality and reliability of medical devices.

Latest Patents

Farnbach holds a patent for an in-line bubble removal mechanism. This innovative mechanism is designed to prevent or inhibit bubbles of dissolved gases from outgassing due to the phase change phenomenon of the pressure differential inside a liquid-filled incompressible line. The application of this mechanism is particularly valuable in the coating of stents and scaffolds, which are critical components in various medical procedures.

Career Highlights

Ronald Farnbach is currently employed at Abbott Cardiovascular Systems, Inc., a leading company in the development of cardiovascular devices. His role at Abbott allows him to apply his inventive skills to create solutions that improve patient outcomes. With a focus on innovation, Farnbach has contributed to the advancement of medical technology.

Collaborations

Farnbach has worked alongside talented colleagues, including Hung T Nguyen and Matthew J Gillick. These collaborations have fostered an environment of creativity and innovation, leading to the development of groundbreaking medical solutions.

Conclusion

In summary, Ronald Farnbach is an accomplished inventor whose work in the medical device industry has led to significant advancements. His patent for the in-line bubble removal mechanism exemplifies his commitment to improving medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…